Uncategorized

For the first half of FY25, the company reported sales volume of 14.79 lakh ton, an increase of 11% year-on-year.

Post Content

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose nearly 1%, reflecting investor confidence despite past regulatory issues.

There is a cautious approach due to strong sector rotation, as traders look for global cues to guide market direction early in the series. This mixed sentiment may lead to volatility in October.

Shares of RVNL have corrected nearly 20% from their recent peak of ₹647.

An expert pointed out that gold recently dropped more than 2% from its all-time high of $2,707 per ounce (₹76,500 per 10 grams)

Out of the 10 analysts that have coverage on NALCO, four of them have a “buy” recommendation on the stock, while three each have a “hold” and “sell” rating. 

Escorts Kubota’s exports continued to decline and took a massive hit of 47% YoY in September 2024.

As per the terms of the agreement, Sun Pharma will have the exclusive worldwide rights for commercialising Fibromun.

The proceeds from the fresh issue to the extent of ₹625.5 crore will be used for funding working capital requirements of the company, and for general corporate purposes.